Shuangbing Xu
Qingdao University(CN)Union Hospital(CN)Harbin Medical University(CN)Third Affiliated Hospital of Harbin Medical University(CN)Affiliated Hospital of Qingdao University(CN)Wuhan Union Hospital(CN)Union Hospital(CN)Huazhong University of Science and Technology(CN)Hubei University(CN)Guangzhou Medical University(CN)
Publications by Year
Research Areas
Ubiquitin and proteasome pathways, Cancer-related Molecular Pathways, RNA modifications and cancer, Lung Cancer Treatments and Mutations, Epigenetics and DNA Methylation
Most-Cited Works
- → UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance(2020)135 cited
- → MiR-138 suppressed nasopharyngeal carcinoma growth and tumorigenesis by targeting the CCND1 oncogene(2012)117 cited
- → Targeting senescence-like fibroblasts radiosensitizes non–small cell lung cancer and reduces radiation-induced pulmonary fibrosis(2021)113 cited
- → USP9X-mediated KDM4C deubiquitination promotes lung cancer radioresistance by epigenetically inducing TGF-β2 transcription(2021)96 cited
- → CDK7 inhibitor THZ1 enhances antiPD-1 therapy efficacy via the p38α/MYC/PD-L1 signaling in non-small cell lung cancer(2020)86 cited
- → Targeting KDM4C enhances CD8+ T cell mediated antitumor immunity by activating chemokine CXCL10 transcription in lung cancer(2022)81 cited